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Abstract
This study aims to estimate the impact of a potential Medicaid expansion on Texas hospitals. The Affordable Care Act (ACA)
Medicaid expansion increased access to health care and improved health outcomes. Still, several states, including Texas,
have not adopted the expansion. This is a retrospective quasi-experimental study. We obtained inpatient data containing
discharges from Texas hospitals between 2010 and 2017 from the Texas Department of State Health Services. Texas
hospitals receive a significant number of patients from the adjacent states. We use a difference-in-differences methodology,
where the patients from the neighboring states that expanded Medicaid in 2014 are the treatment group, and those that
reside in Texas are the control group. The outcome variables are the payer mix and the cost of treatment, proxied by
Diagnoses Related Group (DRG) weights assigned by the Centers for Medicare and Medicaid Services (CMS). The Medicaid
expansion is associated with 4.15% lower costs of treatment among the patients from the expansion states (P < .01). Also,
the uninsured rate decreased by 4.7 percentage points (from 11.3%, P < .01), while the share of Medicaid patients increased
by 10.9 percentage points (from 30.7%, P < .01). There are no significant changes in the share of privately insured or Medicare
patients. Texas hospitals can benefit significantly from Medicaid expansion due to reductions in average treatment costs and
the share of the uninsured.
Keywords
Medicaid expansion, Texas Hospital Data, DRG weights, payer mix, difference-in-differences

What is already known:
The ACA Medicaid expansion increased access to health care and improved health outcomes, but some states still have
not adopted the expansion.
What this study adds:
This study uses data from Texas (which has not expanded Medicaid as of 2022) to estimate the impact of a potential
expansion on Texas hospitals. The results suggest that Medicaid expansion is associated with a lower cost of treatment
and a lower share of uninsured.
Policy implications:
Medicaid expansion in Texas is predicted to decrease hospital inpatient costs by millions of dollars every year.

Introduction
The state-level Medicaid expansions play a central role in the
Affordable Care Act (ACA) and are intended to increase
access to health care and improve health outcomes. The literature found that the ACA Medicaid expansion decreased
uninsurance rates,1-6 increased the share of Medicaid discharges,1,3,4,6 and was associated with increased access to
health care and improved health outcomes.1,2,4,7 Medicaid
expansions also benefited hospitals due to reduced uncompensated care.8,9 Studies even found evidence for increased

jobs and average income due to the stimulative effect of the
expansion.10-12 Despite the positive evidence for the ACA
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Medicaid expansion, several states, including Texas, did not
adopt it. This study uses data from Texas to estimate the
impact of a potential Medicaid expansion on Texas
hospitals.
Texas is one of the states that did not expand Medicaid as
of 2022, while all its adjacent states did so. Arkansas and
New Mexico adopted and implemented the expansion at the
beginning of 2014, while Louisiana implemented it in July
2016. The Medicaid expansion in Oklahoma was adopted in
2020 but went into effect on July 1, 2021. Texas hospitals
receive tens of thousands of patients from the neighboring
states every year. The majority of those patients are admitted
to hospitals in areas very close to the state border. Using the
Texas Inpatient dataset that contains discharges from the
Texas hospitals for the years 2010 to 2017, we examine the
impact of potential Medicaid expansion on the payer mix and
average cost of treatment in Texas hospitals. The findings of
this study are significant as more than a third of the uninsured poor adults in states that did not expand Medicaid
reside in Texas.13

Methods
Data
We use the Public Use Data File (PUDF) obtained from the
Texas Department of State Health Services for 2010-2017.14
The PUDF contains discharge-level information for inpatient
hospital stays. The data are quarterly. This study is exempt
from Institutional Review Board approval because data are
anonymized and publicly available.
In our analyses, we include patients from Arkansas and
New Mexico, which adopted Medicaid expansion in 2014.
Louisiana is a late adopter and thus has limited post-expansion observations given our sample period. Oklahoma
expanded at a much later date, which is outside of our sample
period. Patients from Texas make up the control group, and
those from Arkansas and New Mexico are the treatment
group. We only include the hospitals that receive a significant number of patients from the treatment states. More specifically, we keep hospitals where the out-of-state patients
make 0.5% or more of total discharges in any quarter.
The outcomes of interest are the payer mix and the cost of
treatment, which we proxy by Diagnosis Related Groups
(DRG) weights. Because the Centers for Medicare and
Medicaid Services (CMS) is the dominant payer for medical
care in the United States, Medicare’s DRG-based reimbursement schedule is widely used for hospital costs.15 DRG
weights are resource-based relative value weights publicly
available on the CMS website. Since DRG weights represent
the expected payment by the CMS, they can be used to estimate inpatient costs at the hospital level.16,17 The dataset also
reports total charges, but we use DRG weights because
charges are not a reliable measure of payments received by
hospitals.18
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Several patient characteristics including, age, sex, race,
and expected payment sources are available. We classify discharges based on the expected primary source of payment
into 4 insurance categories. The codes for Medicare Part A
and B are included in Medicare; the code for Medicaid
denotes Medicaid patients; self-pay, charity, indigent, or
unknown make up the Uninsured, and private insurances are
included in the Private category. Sex categories are male,
female, and unidentified. Race includes American Indian,
Asian, Black, White, and Other. Age has 27 categories.
Although we use indicators for each age category in the
regression analysis, we report age statistics using 5 broader
age ranges for convenience. We also control for the median
household income in the patients’ zip code of residence
obtained from the American Community Survey.

Statistical Analysis
We first report the baseline differences between the treatment and control groups in the pre-expansion period (20102013) for the entire sample.
We analyze the impact of the Medicaid expansions using
a difference-in-differences methodology. For our main analysis, we exclude patients over 65, as those are already eligible for Medicare, and the expansion is unlikely to affect
them. We estimate the following empirical equation:
yit = β0 + β1 postt + β2treatedi + β3 ( postt * treatedi )
+ ΨX it + γ t + δ s + it

(1)

yit represents the outcome variables, payer status or DRG
weights, for patient i at quarter-year t. postt is the period
after 2014 when the policy became effective. The parameter
of interest is β3 , which captures the differential effect of the
Medicaid expansion on the treatment group. X denotes the
vector of control variables including patient age, race, sex,
and the median income at the patient’s zip code of residence.
We control for quarter-year ( γ t ) as well as state dummies δ s .
Several sensitivity analyses are conducted. Our data
include patients younger than 18. Medicaid expansion may
not have a direct impact on those, but it may have a spillover effect. Studies show a link between expanding parent
Medicaid eligibility and growth in children’s health coverage.19 Nevertheless, we perform a sensitivity analysis
excluding patients <18. Also, the ACA was enacted in
2010 and had several other provisions that became effective
long before 2014. Thus, we exclude 2010 to rule out those
initial provisions that could confound our results. Another
concern is that after Medicaid expansion, Texas hospitals
may reach out to close-by healthcare facilities in the expansion states and request the transfer of patients who are relatively easy to treat and more likely to be insured. Thus, we
repeat our analysis by excluding patients transferred from
other health care facilities to rule out cream-skimming by
Texas hospitals.
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Table 1. Baseline Characteristics.

Patient count
Patient share (%)
Payer source %
Medicare
Medicaid
Private
Uninsured
Race %
American Indian
Asian
Black
White
Other
Sex %
Female
Male
Unknown
Age %
0-17
18-44
45-64
65-74
>75
Median income ($)

Control

Treatment

Control - Treatment

1 462 283
92.92

111 434
7.08

30.37
19.39
41.04
9.20

38.27
19.86
34.40
7.47

–7.90**
–0.47**
6.64**
1.73**

1.16
1.03
9.46
65.05
23.3

3.26
0.39
11.03
70.14
15.19

–2.10**
0.65**
–1.57**
–5.09**
8.11**

55.05
38.61
6.35

53.62
40.93
5.45

1.42**
–2.32**
0.90**

20.22
25.09
24.91
13.44
16.33
59 458

16.75
21.85
25.49
16.96
18.95
40 823

3.47**
3.24**
–0.58**
–3.52**
–2.62**
18 634**

Baseline characteristics of the entire sample in the pre-policy period (2010-2013). Average shares of discharges in each category or means are shown
for categorical and numerical variables, respectively. The treatment group is patients from Arkansas or New Mexico, which expanded Medicaid in 2014.
The control group is patients from Texas. The last column reports the differences between the groups and whether those differences are statistically
significant based on t-tests.
**P < .01.

We use our full sample, including patients over 65, to find
out the impact of the expansion on the share of Private and
Medicare discharges. We expect Medicaid expansion does
not affect the share of Medicare discharges since individuals
eligible for Medicare are unaffected by the policy. This provides a falsification test for our analysis. The results also
reveal if the public insurance expansion resulted in crowding-out of private insurance.
We also check if the parallel trends assumption, which is
essential for the validity of a difference-in-differences analysis, is satisfied. We run the following linear regression for the
years before the expansion:
yit = α 0 + α1treatedi
2013

+

∑ (α

2,t yeart

+ α3,t ( yeart *treatedi ) )

(2)

t = 2010

+ ψX it + γ t + δ s + σit
The parallel trends assumption requires the outcomes
variables to be similar before the policy was implemented.
The interaction of the treatment and year dummies captures
the difference between the treatment and control groups

over the years. The parallel trends assumption is valid if
α3,t = 0, ∀t ,4, 20 .

Results
More than 3 million discharge records from 108 hospitals are
used, with an average of 400 000 per year. Table 1 shows the
baseline differences between the treatment and control
groups. The treatment group makes up 7% of the total sample. The treatment group is more likely to have Medicare or
Medicaid and less likely to be privately insured or uninsured.
The control group discharges are more likely to be Asian or
other races. They are also more likely to be female or of
unknown/unidentified sex. The treatment group has a
higher share of patients in older age categories. The patients
in the control group are from zip codes with higher median
incomes.
Table 2 shows the averages of outcome variables in the
pre and post-expansion periods for the treatment and control
groups, as well as the adjusted and unadjusted differencein-differences. Average DRG weights increase from preexpansion to post-expansion period for both the treatment
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Table 2. Changes in Outcome Variables.
Treatment

DRG weights
Medicaid
Uninsured

Pre

Post

Pre

Post

1.447
0.307
0.113

1.536
0.390
0.073

1.309
0.275
0.126

1.441
0.243
0.131

Control

Difference in differences

Unadjusted (95% CI)

Adjusted (95% CI)

–0.043 (–0.059, –0.027)**
0.114 (0.110, 0.119)**
–0.044 (–0.048, –0.041)**

–0.060 (–0.104, –0.016)**
0.109 (0.072, 0.145)**
–0.047 (–0.071, –0.024)**

The sample includes patients <65. The treatment group is patients from Arkansas or New Mexico (expanded Medicaid in 2014). The control group
is patients from Texas. Pre is the period before the Medicaid expansion (2010-2013), Post is the period after the expansion (2014-2017). DRG =
Diagnostic Related Group; CI = Confidence Interval. Each DRG weight represents the average resources required to care for cases in that particular
DRG relative to the average resources used to treat cases in all DRGs (CMS). The average relative weight is 1. DRGs with higher relative weights are
more resource-intensive to treat, while DRGs with lower weights are less resource-intensive. Medicaid and Uninsured show the shares of Medicaid and
uninsured discharges. The adjusted differences are from regressions controlling patients’ age, race, sex, median income at the zip code of residence, yearquarter and state dummies.
**P < .01.

Table 3. Changes in Payer Mix.
Treatment

Medicare
Medicaid
Private
Uninsured

Pre

Post

Pre

Post

0.383
0.199
0.344
0.075

0.322
0.250
0.378
0.050

0.304
0.194
0.410
0.092

0.275
0.167
0.463
0.094

Control

Difference in differences

Unadjusted (95% CI)

Adjusted (95% CI)

–0.031 (–0.035, –0.028)**
0.078 (0.075, 0.081)**
–0.019 (–0.024, –0.015)**
–0.027 (–0.030, –0.025)**

–0.016 (–0.055, 0.023)
0.068 (0.043, 0.092)**
–0.020 (–0.065, 0.024)
–0.031 (–0.047, –0.016)**

The full sample of discharges, including patients >65, is used. Each row shows the share of discharges in the corresponding category. The treatment
group is patients from Arkansas or New Mexico (expanded Medicaid in 2014). The control group is patients from Texas. Pre is the period before the
Medicaid expansion (2010-2013), Post is the period after the expansion (2014-2017). CI = Confidence Interval. Adjusted differences are from regressions
controlling patients’ age, race, sex, median income at the zip code of residence, and year-quarter and state dummies.
**P < .01.

and control groups. However, the increase is milder for the
former. Compared to the baseline values, the average DRG is
about 4.15% lower in the post-expansion period for the
patients from the expansion states. The share of Medicaid
discharges increases among the patients from the expansion
states but decreases among the patients in the control group.
On the contrary, the percentage of the uninsured decreases
among the treatment group but increases slightly among the
control group. Compared to the baseline averages, the uninsured rate is lower by 4.7 percentage points, while the share
of Medicaid patients is higher by 10.9 percentage points.
Using our full sample, we estimate the impact of the
expansion on all payer types, including Medicare and Private
insurance. Table 3 reveals that the share of uninsured
decreases while the share of Medicaid discharges increases
among the treatment group compared to the control group.
However, there are no significant changes in the shares of
Medicare or Privately insured following the expansion once
we adjust for patient characteristics. This confirms our falsification test. As expected, the expansion does not affect
Medicare discharges. And there is no evidence of a crowding-out effect.
Figure 1 plots the estimated predictive margins of the
year-treatment interactions obtained from equation (2) along
with their 95% confidence interval. The visual inspection

suggests clear parallel trends for panel (a) and (b) but not for
the others. However, for all outcome variables, the coefficient estimates of the year-treatment interactions (not
reported) are not statistically significant at a 5% significance
level. This indicates that the outcome variables were not statistically different between the treatment and control groups
prior to the policy.
Our results reveal 2 potential mechanisms for cost savings
by Texas hospitals due to the Medicaid expansion: The average cost of inpatient treatment decreases (lower DRGs), and
the uninsured rate decreases. However, if Medicaid expansion increases hospital admissions, the former cost advantages may be negated or outweighed. We check if the share
of patients from the states that expanded Medicaid has
increased significantly after the expansion. The results in the
Appendix show that the Medicaid expansion does not change
the trend of out-of-state patients treated in Texas. Also
included in the Appendix are sensitivity analyses that show
our findings are robust.

Discussion and Conclusion
We find that Medicaid expansion is associated with lower
average DRG weights, a lower share of uninsured, and a
higher share of Medicaid discharges among the patients from
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Figure 1. Parallel trends.

The figure shows the predictive margins of the year-treated interactions in equation (2) for each outcome variable along with their 95% confidence
intervals. DRG = Diagnostic Related Group.

the expansion states treated in Texas hospitals. Our findings
suggest that Texas hospitals can benefit from Medicaid
expansion because of the lower average cost of treatment
(lower DRGs) and reduced cost of uncompensated care
(smaller share of uninsured). We did not find evidence for a

systematic change in the share of out-of-state patients seeking treatment in Texas hospitals following the expansion.
The results imply a 4.15% decrease in average DRG weights,
which translates into $360 lower costs per patient. Therefore,
Medicaid expansion in Texas is predicted to decrease

6
hospital in-patient costs by millions of dollars every year.
Besides, the American Rescue Plan Act of 2021 encourages
non-expansion states to take up the expansion by providing
an additional temporary fiscal incentive for states to newly
implement the ACA Medicaid expansion. Texas is expected
to gain net positive fiscal benefits on top of providing potential health benefits for its residents by expanding Medicaid.21
Our findings of the payer mix are as expected and in line
with the literature. Medicaid expansion is intended to provide insurance to low-income adults who fall in the coverage
gap (those with incomes above their state’s eligibility for
Medicaid but below poverty, the minimum income eligibility
for tax credits through the ACA marketplace). The decrease
in the DRG weights may indicate that expanding Medicaid
eligibility and covering low-income adults can improve
health outcomes. Those patients can get more timely care
and thus are less likely to end up in worse conditions that are
harder and costlier to treat.
Even though the results are robust, our analysis relies on
an administrative dataset with some limitations. The data are
quarterly, but providers have, by law, until the next quarter
(following the discharge) to submit their data. Thus, each
quarter may contain some discharges dated in the previous
quarter. Since our pre- and post-expansion periods consist of
several quarters, we believe having a quarter lag would not
create a significant problem. Also, race and ethnicity information are generally not collected by hospitals and may be
subjectively captured.14 We do not use ethnicity information
because it is not consistent and fluctuates significantly over
time. Race data are relatively more consistent, but we still
use race categories as a control variable and do not draw conclusions based on race.
Another concern is that patients from the neighboring
states may be different from those from Texas seeking care in
their own state. In our sample, we include hospitals that have
a large share of out-of-state patients. Those hospitals are very
close to the state border. The advantage of our design is that
the treatment and control groups consist of patients who are
from areas within close proximity. Thus, they are likely to
have comparable socioeconomic characteristics. On the
other hand, those out-of-state patients might have more serious conditions that warrant them seeking care elsewhere. In
fact, the average DRG weights are higher for those patients
both before and after the expansion. However, the differences-in-differences method does not necessitate the 2
groups to be homogenous. The differences between treatment and control groups are taken care of as long as no other
factor affects the 2 groups differentially before and after the
treatment. Figure 1 shows that even though the average DRG
weights are different, they have similar trends in the preexpansion period. Also, the falsification test we conducted
ensures there are no factors that could result in differential
trends after the expansion.
Lastly, our treatment group includes patients from
Arkansas, which expanded Medicaid through the private
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option, and New Mexico, which adopted traditional Medicaid
expansion. This may raise questions about the validity of the
treatment group. But the earlier research found similar conclusions regarding the effects of the private option and traditional Medicaid expansions.2 Also, we include state dummies
in our regressions.

Appendix
Patients from the Neighboring Expansion States
Even if Medicaid expansion reduces the uninsurance rate and
improves health outcomes, the potential financial gains from
these effects can be nulled by an increase in healthcare
demand if there is an increase in the volume of patients. We
check if there is a significant change in the number of discharges from the adjacent states that expanded Medicaid.
We compute the share of patients from the expansion
states in each period for each hospital and estimate the following empirical equation:
yit = β0 + β1timet + β2 postt

+ β3 ( postt * timet ) + Ωi + γ t + ψ it

(3)

where yit is the share of patients from the expansion states
in hospital i at year-quarter t. timet captures the quarterly
time trend. postt is another dummy that shows the period
starting from the first quarter of 2014 when the policy is
implemented. β1 and β3 capture the trends before and after
the policy, while β2 captures the difference in the average
out-of-state patient shares before and after the policy. A
positive and significant β2 would indicate that Texas
hospitals received more patients from the expansion states
following the expansion. Similarly, a positive β3 would
indicate a steeper trend after the expansion. We include
time ( γ t ) and hospital fixed effects (Ωi). The sample has
108 hospitals.
Table A1 shows an overall increasing trend of out-of-state
patients seeking treatment in Texas hospitals. The share of
out-of-state patients after the Medicaid expansion is higher
by about 4 percentage points, but the coefficient is not statistically significant. The interaction term is negative, which
Table A1. Share of Out-of-State Patients.
Time
Post
Post × time
Observations
Number of hospitals

0.045 (–0.006, 0.096)
4.337 (–14.54, 23.21)
–0.146 (–0.767, 0.474)
2742
108

95% Confidence intervals are in parentheses. The dependent variable is
the hospital- level share of patients from the expansion states. time is a
quarterly time trend. post is a dummy and equals 1 if the observation is
from a period after the Medicaid expansion. Hospital and year-quarter
fixed effects are included. Standard errors clustered at the hospital level.

Saygili

7

Table A2. Robustness Checks: Adjusted Difference in Differences.

DRG weights
Medicaid
Uninsured

Exclude age <18

Exclude 2010

Exclude transfers

Diff-diff (95% CI)

Diff-diff (95% CI)

Diff-diff (95% CI)

–0.030 (–0.049, –0.012)**
0.116 (0.112, 0.121)**
–0.066 (–0.070, –0.062)**

–0.060 (–0.102, –0.018)**
0.086 (0.055, 0.117)**
–0.046 (–0.071, –0.024)**

–0.063 (–0.104, –0.021)**
0.107 (0.065, 0.149)**
–0.044 (–0.071, –0.017)**

Adjusted difference-in-differences coefficients along with their 95% confidence intervals are reported. The regressions adjust for patients’ age, race, sex,
median income at the zip code of residence, and year-quarter and state dummies. DRG = Diagnostic Related Group; CI = Confidence Interval; Diff-diff
= Difference in differences. Each DRG weight represents the average resources required to care for cases in that particular DRG relative to the average
resources used to treat cases in all DRGs (CMS). The average relative weight is 1. DRGs with higher relative weights are more resource-intensive to
treat, while DRGs with lower weights are less resource-intensive.
** P < .01.

suggests that the trend after the expansion is lower, but it is
statistically insignificant.

Sensitivity Analyses
The ACA Medicaid expansion primarily benefits lowincome adults as children are already eligible for Medicaid
or CHIP. We included children in our sample because studies
show a link between expanding parent Medicaid eligibility
and growth in children’s health coverage. We perform a sensitivity analysis by excluding patients younger than 18. The
ACA was enacted in 2010 and had several other provisions
that became effective long before 2014. We exclude the year
2010 to rule out those initial provisions of the ACA that
could affect the results. We also repeat our analysis by
excluding patients transferred from other health care facilities to rule out cream-skimming by Texas hospitals following
the expansion. Table A2 reveal that the results are robust and
consistent across different scenarios.
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